Real-life effectiveness of rituximab in different subsets of idiopathic inflammatory myopathies

Real-life effectiveness of rituximab in different subsets of idiopathic inflammatory myopathies

Objective. Idiopathic inflammatory myopathies (IIM) are heterogeneous autoimmune diseases including dermatomyositis (DM), polymyositis (PM), immune-mediated necrotizing myopathy (IMNM), and anti-synthetase syndrome (ASS). Treatment typically involves high-dose corticosteroids (CCS) and conventional...

Full description

Saved in:
Bibliographic Details
Main Authors: Stefano Stano, Fabio Cacciapaglia, Laura Coladonato, Giuseppe Lopalco, Florenzo Iannone, Marco Fornaro
Format: Article
Language:English
Published: PAGEPress Publications 2025-04-01
Series:Reumatismo
Subjects:
Myositis
rituximab
safety
effectiveness
Online Access:https://www.reumatismo.org/reuma/article/view/1817
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items